Rare diseases
Investigational molecules
Locations
Study on Ceralasertib, Oleclumab, and Monalizumab for Advanced Non-Small Cell Lung Cancer Patients Resistant to PD-1 Inhibitors
FranceStudy of Nivolumab and Relatlimab for Adults with Advanced or Metastatic Soft-Tissue Sarcoma
FranceStudy on Botulinum Toxin Type A to Prevent Pancreatic Fistulas in Patients Undergoing Distal Pancreatectomy
The NetherlandsStudy on the Effect of Low-Dose Aspirin in Preventing New or Recurrent Colorectal Polyps in Patients with Lynch Syndrome
FranceStudy on the Effects of Atezolizumab, Trastuzumab, and Pertuzumab in Patients with Early-Stage Triple-Negative or HER2+ Breast Cancer
FranceStudy on the Safety and Effectiveness of Azacitidine and Venetoclax for Patients with Higher-Risk Chronic Myelomonocytic Leukemia (CMML)
FranceStudy of decitabine and cedazuridine combination in patients with lower-risk myelodysplastic syndromes
BelgiumStudy on the Effectiveness of Aspirin in Patients with Resected Colon Cancer with PI3K Mutation Stage III or II High Risk
FranceStudy of belantamab mafodotin with bortezomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma patients eligible for transplant
SpainStudy on the Safety and Tolerability of Guanabenz in Children with Vanishing White Matter Disease
The NetherlandsStudy of dose reduction strategy for tyrosine kinase inhibitors (imatinib, ponatinib, bosutinib, nilotinib, dasatinib) in patients with chronic myeloid leukemia
The NetherlandsStudy on the Effects of Glycerol Phenylbutyrate in Patients with Corticobasal Syndrome
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
